Alberto
Benito Boillos
Consultor Médico
José Ignacio
Herrero Santos
Consultor Médico
Publicacions en què col·labora amb José Ignacio Herrero Santos (27)
2024
2023
-
Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease
Journal of Physiology and Biochemistry
-
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
Cancers, Vol. 15, Núm. 3
2022
-
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers
Panminerva medica, Vol. 64, Núm. 4, pp. 485-496
2021
-
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study
European Journal of Nutrition, Vol. 60, Núm. 4, pp. 1769-1780
-
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study
European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057
-
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial
Liver International, Vol. 41, Núm. 7, pp. 1532-1544
-
Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study
Diagnostics, Vol. 11, Núm. 6
2020
2019
-
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study
Nutrients, Vol. 11, Núm. 10
-
Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: A comparison with healthy controls
Nutrients, Vol. 11, Núm. 2
-
The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: The fatty liver in obesity (FLiO) randomized controlled trial
Nutrients, Vol. 11, Núm. 10
-
Ultrasound/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults
International Journal of Medical Sciences, Vol. 16, Núm. 1, pp. 75-83
2018
-
Interplay of glycemic index, glycemic load, and dietary antioxidant capacity with insulin resistance in subjects with a cardiometabolic risk profile
International Journal of Molecular Sciences, Vol. 19, Núm. 11
2017
-
Totally laparoscopic right hepatectomy for living donor liver transplantation: Analysis of a preliminary experience on 5 consecutive cases
Transplantation, Vol. 101, Núm. 3, pp. 548-554
2014
-
Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?
Transplantation Proceedings
2013
-
Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology, Vol. 57, Núm. 3, pp. 1078-1087
-
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: Useful strategies to enhance safety
American Journal of Transplantation, Vol. 13, Núm. 12, pp. 3269-3273
2012
-
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma
European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601
2011
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971